Nobuko Okada

Title: Nobuko Okada: Innovator in Antitumor Agents

Introduction

Nobuko Okada is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. Her innovative work has led to the creation of a novel compound that holds promise in cancer treatment.

Latest Patents

Nobuko Okada holds a patent for a 2-piperidinecarboxylic acid derivative, which is recognized for its oncogene suppressor properties. This compound is represented by a specific formula, wherein X can be an oxygen atom, a sulfur atom, or a nitrogen atom bound to a hydrogen atom. The configuration of the carbon atom binding to the carboxyl group can be (S), (R), or a mixture of both. This derivative, along with its pharmaceutically acceptable salts, exhibits an antitumor effect across a wide range of tumor cells. She has 1 patent to her name.

Career Highlights

Nobuko Okada is associated with Meiji Seika Kaisha, Ltd., where she continues to advance her research and development efforts. Her work is pivotal in the pharmaceutical industry, contributing to innovative solutions for cancer treatment.

Collaborations

Nobuko has collaborated with notable colleagues, including Tsuneo Okonogi and Osamu Makabe. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Nobuko Okada's contributions to the field of pharmaceuticals, particularly in developing antitumor agents, highlight her role as an influential inventor. Her innovative work continues to pave the way for advancements in cancer treatment.